MucoLife Therapeutics AB
559463-2159ActiveDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Biotechnology Companymucolife.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2023
- Perustettu
Avainpäättäjät
Dr. Maarten Kraan
Board of Directors
Kuvaus
MucoLife Therapeutics is a pioneering biotechnology firm dedicated to transforming the treatment landscape for chronic lung diseases. The company specifically targets pulmonary mucus obstruction, a debilitating symptom affecting patients with conditions like Chronic Obstructive Pulmonary Disease (CO...
Tunnisteet
B2BHealthTech